Pancreatitis clinical trials at UCSF

3 in progress, 2 open to eligible people

Showing trials for

  • SpHincterotomy for Acute Recurrent Pancreatitis

    open to eligible people ages 18 years and up

    The purpose of this study is to determine if a procedure called Endoscopic Retrograde CholangioPancreatography (ERCP) with sphincterotomy reduces the risk of pancreatitis or the number of recurrent pancreatitis episodes in patients with pancreas divisum. ERCP with sphincterotomy is a procedure where doctors used a combination of x-rays and an endoscope (a long flexible lighted tube) to find the opening of the duct where fluid drains out of the pancreas. People who have been diagnosed with pancreas divisum, have had at least two episodes of pancreatitis, and are candidates for the ERCP with sphincterotomy procedure may be eligible to participate. Participants will be will be randomly assigned to either have the ERCP with sphincterotomy procedure, or to have a "sham" procedure. Participants will have follow up visits 30 days after the procedure, 6 months after the procedure, and continuing every 6 months until a maximum follow-up period of 48 months.

    San Francisco, California and other locations

  • A Prospective Observational Study of TPIAT

    open to all eligible people

    Multi-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)

    San Francisco, California and other locations

  • PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms

    Sorry, in progress, not accepting new patients

    The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.

    San Francisco, California and other locations

Our lead scientists for Pancreatitis research studies include .

Last updated: